Phase 2 study

Recruiting Phase 2

Sources: ClinicalTrials.gov Checked: 11 October 2026 Not medical advice

This trial at a glance

Status Recruiting
Phase Phase 2
Sponsor Frontier Medicines Corporation
Registry number NCT06244771
Started 12 February 2024 Today 16 October 2026 Estimated completion 1 October 2027

Where this trial is running

Trial sites and the status recorded for each
SiteCityState or countryStatus at this site
Macquarie University Macquarie Park NSW Recruiting
Tasman Health Care Southport QLD Recruiting
Icon Cancer Centre Kurralta Park Kurralta Park SA Recruiting
GenesisCare North Adelaide North Adelaide SA Recruiting
Eastern Health - Box Hill Hospital Box Hill VIC Recruiting
Linear Clinical Research Ltd Nedlands WA Recruiting

voxsanity.com.au · trial sites from public registries · registry record synced 11 October 2026 · not medical advice

Who can join

Age 18 Years and over
Sex Anyone, regardless of sex
Healthy volunteers Not accepted
Enrolment target 403

The official eligibility criteria

Registry text, reproduced exactly. These are the words the trial's sponsor published on ClinicalTrials.gov. They have not been edited, shortened or rewritten, and they are written for researchers rather than for patients.

Inclusion Criteria:

* Histologically or cytologically confirmed locally advanced unresectable or metastatic solid tumors with KRAS G12C mutation

* Received and progressed or been intolerant to prior standard therapy OR standard therapy is considered inappropriate OR an investigational agent is considered standard of care

* Eastern Cooperative Oncology Group (ECOG) performance status 0 or 1

* Adequate hematological, renal, and hepatic function

* Agrees not to participate in another interventional study while receiving study drug

Exclusion Criteria:

* Leptomeningeal disease or carcinomatous meningitis

* Clinically significant toxicity resulting from prior cancer therapies

* Known or suspected hypersensitivity to FMC-376 or any components of the study drug

* Condition that would interfere with study drug absorption

* Any illness or medical history that would impact safety or compliance with study requirements or impact ability to interpret study data

Dates on the record

Started 12 February 2024
Estimated completion 1 October 2027
Registry last updated 18 March 2026
Checked by Voxsanity 11 October 2026

Results, publications and the official record

Sources and dates

  • ClinicalTrials.gov – the record this page reformats
  • ClinicalTrials.gov processing date: 18 March 2026.
  • This page last checked by Voxsanity: 11 October 2026.

Voxsanity reformats data from public registries into this layout. It does not edit, interpret or add to what the registry published.

Not medical advice.

Individual trial records are refreshed on a rolling basis rather than all at once, so a record may be up to several weeks old. Each trial page and trial card shows the date its own record was last synced. Where a record has lagged, its status, sites and enrolment can differ from the current registry state in either direction, so check the registry link on the trial page before acting on them.

Letter for your doctor

A one-page summary of this trial to print or email to your GP. It carries the registry's own record of the trial and its eligibility criteria, and nothing Voxsanity has written about whether it suits you.